Aromatase Plus GnRH Analogue Versus Ulippristal Acetate in Uterine Fibroids

• Status: Unknown status
• Trial end date: 2020-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

With this study the investigators want to test which is the best medical treatment for symptomatic uterine fibroid, mostly abnormal uterine bleeding, between Ulipristal acetate versus Aromatase inhibitor plus GnRH analog, in term of uterine and fibroid volume reduction

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
• Treatments: Aromatase Inhibitors; Ulipristal acetate

Criteria

Inclusion Criteria:

• women with healty conditions

• abnormal menstrual bleeding

• increased uterine dimensions

• presence of at least two uterine fibroid

Exclusion Criteria:

• presence of systemic diseases